CSI Frankfurt 2019 - Home


June 26 – 29, 2019
Frankfurt, Germany

CSI Frankfurt 2019: Catheter Interventions in Congenital, Structural and Valvular Heart Disease - CSI 2019 CSI 2019 Catheter Interventions in Congenital, Structural and Valvular Heart Disease
CSI Frankfurt 2019
CSI Frankfurt 2019

Save the Date!
June 26 – 29, 2019 | Frankfurt, Germany
csi pfeil
Newsletter subscription

PodCase
of the Month  
Interatrial shunting and fenestrated ASD devices
csi pfeil
watch now free of charge

Add to my calendar
CSI 2019 Congress overview Access CSI 2018 Scientific program Focus workshopsDevice DevelopmentPFOPulmonary Valve ImplantationParavalvar LeakMitral ValveTAVIVSDNeonatal InterventionsTricuspid ValveLAA ClosureHeart Failure InterventionsASDPDACoarctationPulmonary Artery Stenosis
Training hub Abstracts and cases Scientific faculty Attendee information Industry Impressions and references CSI@home Downloads Archive Event calendar Contact
Fontsize bigger
  CSI Frankfurt 2019: Catheter Interventions in Congenital, Structural and Valvular Heart Disease
CSI Frankfurt 2019: Catheter Interventions in Congenital, Structural and Valvular Heart Disease

CSI Focus: TAVI

Transcatheter aortic valve implantation (TAVI) has become the most common structural intervention in adult cardiology, with the annual number of TAVIs surpassing the number of conventional aortic valve replacement in many countries. Transcatheter technology has improved at a rapid pace and has allowed aortic valve implantations with low rates of complications. Nevertheless, a number of clinical and technical challenges remain. For example, the best approach to bicuspid aortic valves, asymptomatic severe aortic stenosis, moderate aortic stenosis in the setting of a reduced left ventricular systolic function, severe aortic stenosis in low surgical risk patients and pure aortic regurgitation has yet to be determined. Furthermore, cerebral protection strategies are evolving and the best post-procedural antiplatelet and anticoagulant therapy are being evaluated. Finally, though less common in the current era, complications such as residual paravalvar regurgitation, valve thrombus, coronary occlusion, complete heart block and vascular injury continue to occur.

CSI 2019 will be holding a comprehensive TAVI workshop on Thursday, June 27, that will review the role of TAVI for the treatment of aortic valve disease, address aforementioned challenges, provide an overview of novel technologies and showcase experienced operators during live case transmissions.


See you at CSI Frankfurt!

Horst Sievert, Mario Carminati, Shakeel A. Qureshi


View the focus workshop here
View the complete conference program overview here
Register here

CSI Foundation

This meeting will be organised by the CSI Foundation, a not-for-profit organization formed to aid the development of structural, congenital and valvar heart interventions worldwide. CSI Foundation members will receive discounted entry to this event. For more information, please visit the CSI Foundation webpage

CSI   CSI
Contact Data Privacy Imprint Home Visit us on Facebook Visit us on Twitter